Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim J Hagan

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Opinion in Pharmacology|January 22, 2005
Novel pharmacotherapeutic approaches for the treatment of drug addiction and cravingChristian A Heidbreder, Jim J Hagan
Current Drug Targets. CNS and Neurological Disorders|February 18, 2004
5-HT7 receptorsDavid R Thomas, Jim J Hagan
Schizophrenia Bulletin|September 24, 2005
Predicting drug efficacy for cognitive deficits in schizophreniaJim J Hagan, Declan N C Jones
Synapse (New York, N.Y.)|November 18, 2003
5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortexLaurent P Lacroix, Lee A Dawson, Jim J Hagan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-APatricia Di Ciano, Rachel J Underwood, Jim J Hagan, et al.
Neuropharmacology|December 26, 2001
5-HT7 receptors modulate synchronized network activity in rat hippocampusCatherine H Gill, Ellen M Soffin, Jim J Hagan, et al.
European Journal of Pharmacology|June 28, 2005
Effect of vilazodone on 5-HT efflux and re-uptake in the guinea-pig dorsal raphe nucleusClaire Roberts, Jim J Hagan, Gerd D Bartoszyk, et al.
Behavioral Neuroscience|May 31, 2012
Enhanced appetitive learning and reversal learning in a mouse model for Prader-Willi syndromeDinko Relkovic, Trevor Humby, Jim J Hagan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behaviorMichela Andreoli, Michela Tessari, Maria Pilla, et al.
Synapse (New York, N.Y.)|March 20, 2003
Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male ratsCharles R Ashby, Mousumi Paul, Eliot L Gardner, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Opinion in Pharmacology|January 22, 2005
Novel pharmacotherapeutic approaches for the treatment of drug addiction and cravingChristian A Heidbreder, Jim J Hagan
Current Drug Targets. CNS and Neurological Disorders|February 18, 2004
5-HT7 receptorsDavid R Thomas, Jim J Hagan
Schizophrenia Bulletin|September 24, 2005
Predicting drug efficacy for cognitive deficits in schizophreniaJim J Hagan, Declan N C Jones
Synapse (New York, N.Y.)|November 18, 2003
5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortexLaurent P Lacroix, Lee A Dawson, Jim J Hagan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 18, 2003
Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-APatricia Di Ciano, Rachel J Underwood, Jim J Hagan, et al.
Neuropharmacology|December 26, 2001
5-HT7 receptors modulate synchronized network activity in rat hippocampusCatherine H Gill, Ellen M Soffin, Jim J Hagan, et al.
European Journal of Pharmacology|June 28, 2005
Effect of vilazodone on 5-HT efflux and re-uptake in the guinea-pig dorsal raphe nucleusClaire Roberts, Jim J Hagan, Gerd D Bartoszyk, et al.
Behavioral Neuroscience|May 31, 2012
Enhanced appetitive learning and reversal learning in a mouse model for Prader-Willi syndromeDinko Relkovic, Trevor Humby, Jim J Hagan, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2003
Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behaviorMichela Andreoli, Michela Tessari, Maria Pilla, et al.
Synapse (New York, N.Y.)|March 20, 2003
Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male ratsCharles R Ashby, Mousumi Paul, Eliot L Gardner, et al.
Pageof 4